These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26374128)
1. Opioid dependency rehabilitation with the opioid maintenance treatment programme - a qualitative study from the clients' perspective. Granerud A; Toft H Subst Abuse Treat Prev Policy; 2015 Sep; 10():35. PubMed ID: 26374128 [TBL] [Abstract][Full Text] [Related]
2. Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications. Muller AE; Bjørnestad R; Clausen T Drug Alcohol Depend; 2018 Jun; 187():22-28. PubMed ID: 29626742 [TBL] [Abstract][Full Text] [Related]
3. The paradox of control: An ethnographic analysis of opiate maintenance treatment in a Norwegian prison. Mjåland K Int J Drug Policy; 2015 Aug; 26(8):781-9. PubMed ID: 26025481 [TBL] [Abstract][Full Text] [Related]
4. Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine. Heikman PK; Muhonen LH; Ojanperä IA BMC Psychiatry; 2017 Jul; 17(1):245. PubMed ID: 28683783 [TBL] [Abstract][Full Text] [Related]
5. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101 [TBL] [Abstract][Full Text] [Related]
6. From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme. Riksheim M; Gossop M; Clausen T J Subst Abuse Treat; 2014 Mar; 46(3):291-4. PubMed ID: 24210532 [TBL] [Abstract][Full Text] [Related]
7. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study. Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400 [TBL] [Abstract][Full Text] [Related]
8. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Dunn KE; Finan PH; Andrew Tompkins D; Strain EC Addict Behav; 2018 Jan; 76():8-14. PubMed ID: 28735039 [TBL] [Abstract][Full Text] [Related]
9. Consumer attitudes about opioid addiction treatment: a focus group study in New York City. Sohler NL; Weiss L; Egan JE; López CM; Favaro J; Cordero R; Cunningham CO J Opioid Manag; 2013; 9(2):111-9. PubMed ID: 23709320 [TBL] [Abstract][Full Text] [Related]
10. Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancy. Welle-Strand GK; Skurtveit S; Abel KF; Chalabianloo F; Sarfi M J Subst Abuse Treat; 2020 Jun; 113():108004. PubMed ID: 32359675 [TBL] [Abstract][Full Text] [Related]
11. Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway. Karlstad Ø; Furu K; Skurtveit S; Selmer R Eur Addict Res; 2014; 20(2):59-65. PubMed ID: 24080771 [TBL] [Abstract][Full Text] [Related]
12. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414 [TBL] [Abstract][Full Text] [Related]
13. Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study. Skeie I; Brekke M; Clausen T; Gossop M; Lindbaek M; Reinertsen E; Thoresen M; Waal H Eur Addict Res; 2013; 19(4):194-201. PubMed ID: 23257574 [TBL] [Abstract][Full Text] [Related]
14. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Holland R; Maskrey V; Swift L; Notley C; Robinson A; Nagar J; Gale T; Kouimtsidis C Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349 [TBL] [Abstract][Full Text] [Related]
15. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services. Moran L; Keenan E; Elmusharaf K BMC Health Serv Res; 2018 Nov; 18(1):911. PubMed ID: 30497467 [TBL] [Abstract][Full Text] [Related]
16. Retention and outcomes for clients attending a methadone clinic in a resource-constrained setting: a mixed methods prospective cohort study in Imphal, Northeast India. Kermode M; Choudhurimayum RS; Rajkumar LS; Haregu T; Armstrong G Harm Reduct J; 2020 Sep; 17(1):68. PubMed ID: 32993646 [TBL] [Abstract][Full Text] [Related]
17. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033 [TBL] [Abstract][Full Text] [Related]
18. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Clausen T; Anchersen K; Waal H Drug Alcohol Depend; 2008 Apr; 94(1-3):151-7. PubMed ID: 18155364 [TBL] [Abstract][Full Text] [Related]
19. 'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'. Havnes IA; Clausen T; Middelthon AL Harm Reduct J; 2013 Oct; 10():24. PubMed ID: 24131626 [TBL] [Abstract][Full Text] [Related]
20. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]